3i Group plc Unsponsored ADR ( (TGOPY) ) has released its Q4 earnings. Here is a breakdown of the information 3i Group plc Unsponsored ADR presented to its investors.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
3i Group plc, a prominent international investment manager, primarily focuses on mid-market private equity and infrastructure investments across Europe and North America. The company is known for its strategic investment approach and its ability to deliver consistent long-term growth, even amid challenging economic conditions.
In its latest earnings report for the year ending March 31, 2025, 3i Group plc reported a total return of £5,049 million, marking a 25% increase on opening shareholders’ funds. The company’s net asset value per share rose to 2,542 pence, up from 2,085 pence the previous year. The Private Equity business was a significant contributor to this growth, with a gross investment return of £5,113 million, driven by strong performances from key portfolio companies like Action and Royal Sanders.
Action, a leading non-food discount retailer, was a standout performer, generating a gross investment return of £4,551 million and achieving a 32% return on its opening value. The company reported a 22% increase in annual revenue and a 29% growth in EBITDA. Additionally, 3i’s Private Equity team made strategic investments totaling £1,177 million, including further stakes in Action and new investments in companies like Constellation and WaterWipes.
The Infrastructure business, while generating a modest gross investment return of £52 million, continued to benefit from dividend and interest income. Overall, 3i Group ended the year with liquidity of £1,323 million and a gearing of 3%. The company declared a total dividend of 73.0 pence per share for the fiscal year 2025.
Looking forward, 3i Group remains optimistic about its ability to compound growth across its portfolio, despite ongoing market uncertainties. The management emphasizes a disciplined approach to new investments and realisations, focusing on sectors that have demonstrated resilience, such as value-for-money consumer goods and healthcare.